Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients
- PMID: 17872364
- DOI: 10.1212/01.wnl.0000265393.03231.e5
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients
Comment in
-
Is natalizumab overshooting its rebound?Neurology. 2008 Mar 25;70(13 Pt 2):1073-4. doi: 10.1212/01.wnl.0000306415.37679.5a. Neurology. 2008. PMID: 18362270 No abstract available.
-
Update. Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients.Neurology. 2008 Sep 2;71(10):780. doi: 10.1212/01.wnl.0000334435.35213.87. Neurology. 2008. PMID: 18765659 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical